Jul 4, 2026 · 9 min
SpaceX joins Nasdaq 100 as earnings season tests consumer demand
Week Ahead: SpaceX To Join Nasdaq 100, PepsiCo & Delta Earnings Preview
The upcoming week of market activity will test whether tech index reshuffling and consumer spending shifts can sustain the stock market's momentum.
- 1SpaceX joining the Nasdaq 100 will force major index-tracking funds to purchase the stock.
- 2PepsiCo earnings will show how weight-loss drugs and cautious consumer spending are impacting food brands.
- 3Delta Air Lines faces pressure as rising fuel costs threaten to offset record summer travel demand.
Don't miss
The analysis of how GLP-1 weight-loss drugs are starting to pressure PepsiCo's snack business.
The brief
SpaceX is set to join the Nasdaq 100 index, a major milestone that will trigger mandatory buying from massive tracking funds like the Invesco QQQ ETF and could introduce new volatility as its underwriter quiet period comes to an end.
At the same time, consumer stock bellwether PepsiCo faces a dual challenge of cautious household spending and the rising popularity of GLP-1 weight-loss drugs, which are beginning to alter consumer appetite for traditional snack brands.
Airlines are also facing a critical test as Delta Air Lines reports earnings. Despite exceptionally strong summer travel demand, rising fuel costs threaten to eat into profit margins and complicate the industry outlook.
What was said on this episode
6 statements · 4 positive · 1 negative · 1 neutral
SpaceX’s Nasdaq-100 inclusion will trigger mandatory purchases by index-tracking funds.
“That inclusion will trigger some mandatory buying for all funds that track this key index, notably the QQQ etf”
Listen at 1:13
SpaceX is valued at $2 trillion and ranks among Nasdaq’s largest companies.
“As a $2 trillion company, Space SpaceX would rank among one of the largest on the NASDAQ.”
Listen at 1:27
SpaceX’s IPO raised $86 billion, a record-breaking amount.
“it also had a record breaking IPO that raised $86 billion.”
Listen at 1:48
SpaceX’s IPO underwriter quiet period will end next week.
“the quiet period for those IPO underwriters to also end next week.”
Listen at 2:32
GLP-1 drugs are pushing some consumers toward healthier food options.
“GLP1s are pushing some consumers to seek out healthier options”
Listen at 3:25
TD Cowen expects Delta to report very strong demand across products and geographies.
“TD Cowan expecting the company to report very strong demand across all products and geographies.”
Listen at 5:26
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Invesco QQQ
GLP-1 receptor agonist
Consumer spendingListen to the full episode and explore every guest, topic, and moment on PodLume.